Upcoming Events
TRYP THERAPEUTICS TO SPEAK & PRESENT AT THE PSYCHED INVESTOR SUMMIT
TRYP THERAPEUTICS TO PRESENT AT THE LADENBURG THALMANN 2021 HEALTHCARE CONFERENCE
San Diego, California--(Newsfile Corp. - June 8, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW) ("Tryp"), a pharmaceutical company focused on developing compounds for diseases with unmet medical needs through accelerated regulatory pathways, announced today that it is presenting at the Ladenburg Thalmann Healthcare Conference. The conference will be held virtually on July 13 and 14. Greg McKee, Chairman and CEO; Jim Gilligan, President and Chief Science Officer; and Luke Hayes, CFO, will provide an overview of Tryp's business and its pipeline followed by a brief analyst-led fireside chat.
Details of the presentation are as follows:
Date: Tuesday, July 13, 2021
Time: 3:00 - 3:25 p.m. EDT
Location: Virtual
Registration: Ladenburg Thalmann 2021 Healthcare Conference
TRYP THERAPEUTICS TO PRESENT AT THE CANACCORD ANNUAL GROWTH CONFERENCE
Past Events
TRYP THERAPEUTICS TO PRESENT AT THE PSYCHEDELIC OPPORTUNITY SUMMIT
TRYP THERAPEUTICS TO PRESENT AT THE H.C. WAINWRIGHT PSYCHEDELICS CONFERENCE
Details of the presentation are as follows:
Date: Thursday, June 17th, 2021
Time: Tryp’s presentation will be available to access beginning at 7:00 a.m. EDT
Registration: https://hcwevents.com/psychedelics/
Canaccord Psychedelic Investment Conference
EDISON Global Healthcare Conference
Tryp Therapeutics, a leading pharmaceutical company focused on identifying and developing clinical-stage compounds for diseases with high unmet medical needs, has been invited to present at the EDISON Global Heathcare Conference.